Cerevel Therapeutics

$15.65
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.16 (-1.01%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CERE and other stocks, options, and ETFs commission-free!

About CERE

Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease.

CEO
N. Anthony Coles
Employees
104
Headquarters
Cambridge, Massachusetts
Founded
—
Market Cap
1.78B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
189.97K
High Today
$16.05
Low Today
$15.31
Open Price
$16.00
Volume
141.45K
52 Week High
$18.84
52 Week Low
$9.00

CERE Earnings

-$0.45
-$0.30
-$0.15
-$0.00
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 12, Pre-Market

You May Also Like

NVMZ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure